Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rahmet Guner

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
BMJ Open|March 15, 2024
Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)Ranjani Somayaji, David R Luke, Arthur Lau, et al.
Journal of Infection and Public Health|March 1, 2021
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravirRahmet Guner, Imran Hasanoglu, Bircan Kayaaslan, et al.
Digestion|December 21, 2013
Lamivudine treatment failure risks in chronic hepatitis B patients with low viral loadSeyfettin Koklu, Murat Taner Gulsen, Yasar Tuna, et al.
International Journal of Antimicrobial Agents|June 26, 2012
Management of Brucella endocarditis: results of the Gulhane studySuda Tekin Koruk, Hakan Erdem, Ibrahim Koruk, et al.
Frontiers in Medicine|October 31, 2022
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patientsHatice Kilic, Emine Arguder, Aysegul Karalezli, et al.
BMC Infectious Diseases|September 26, 2021
Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 casesRahmet Guner, Bircan Kayaaslan, Imran Hasanoglu, et al.
Medicine|July 23, 2025
Diagnosis and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rate of 100 mm/h or more: An International ID-IRI (Infectious Diseases - International Research Initiative) Observational Retrospective Cohort StudyUmran Elbahr, Hakan Erdem, Wissal Ben Yahia, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul studyHakan Erdem, Aysegül Ulu-Kilic, Selim Kilic, et al.
Journal of Clinical Laboratory Analysis|May 19, 2025
Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive ApproachEmre Dirican, Tayibe Bal, Yusuf Onlen, et al.
Annals of Clinical Microbiology and Antimicrobials|December 20, 2011
Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needsHakan Erdem, Suda Tekin-Koruk, Ibrahim Koruk, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
BMJ Open|March 15, 2024
Multicentre, randomised, double-blind, placebo-controlled, proof of concept study of LSALT peptide as prevention of acute respiratory distress syndrome and acute kidney injury in patients infected with SARS-CoV-2 (COVID-19)Ranjani Somayaji, David R Luke, Arthur Lau, et al.
Journal of Infection and Public Health|March 1, 2021
Comparing ICU admission rates of mild/moderate COVID-19 patients treated with hydroxychloroquine, favipiravir, and hydroxychloroquine plus favipiravirRahmet Guner, Imran Hasanoglu, Bircan Kayaaslan, et al.
Digestion|December 21, 2013
Lamivudine treatment failure risks in chronic hepatitis B patients with low viral loadSeyfettin Koklu, Murat Taner Gulsen, Yasar Tuna, et al.
International Journal of Antimicrobial Agents|June 26, 2012
Management of Brucella endocarditis: results of the Gulhane studySuda Tekin Koruk, Hakan Erdem, Ibrahim Koruk, et al.
Frontiers in Medicine|October 31, 2022
Effect of chronic lung diseases on mortality of prevariant COVID-19 pneumonia patientsHatice Kilic, Emine Arguder, Aysegul Karalezli, et al.
BMC Infectious Diseases|September 26, 2021
Development and validation of nomogram to predict severe illness requiring intensive care follow up in hospitalized COVID-19 casesRahmet Guner, Bircan Kayaaslan, Imran Hasanoglu, et al.
Medicine|July 23, 2025
Diagnosis and outcomes of fever of unknown origin cases with an erythrocyte sedimentation rate of 100 mm/h or more: An International ID-IRI (Infectious Diseases - International Research Initiative) Observational Retrospective Cohort StudyUmran Elbahr, Hakan Erdem, Wissal Ben Yahia, et al.
Antimicrobial Agents and Chemotherapy|December 14, 2011
Efficacy and tolerability of antibiotic combinations in neurobrucellosis: results of the Istanbul studyHakan Erdem, Aysegül Ulu-Kilic, Selim Kilic, et al.
Journal of Clinical Laboratory Analysis|May 19, 2025
Assisting the Diagnosis of Cirrhosis in Chronic Hepatitis C Patients Based on Machine Learning Algorithms: A Novel Non-Invasive ApproachEmre Dirican, Tayibe Bal, Yusuf Onlen, et al.
Annals of Clinical Microbiology and Antimicrobials|December 20, 2011
Assessment of the requisites of microbiology based infectious disease training under the pressure of consultation needsHakan Erdem, Suda Tekin-Koruk, Ibrahim Koruk, et al.
Pageof 7